➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Dow
Merck
Harvard Business School
McKesson

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cefotetan And Dextrose In Duplex Container patents expire, and when can generic versions of Cefotetan And Dextrose In Duplex Container launch?

Cefotetan And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.

Summary for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Drug patent expirations by year for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Pharmacology for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

US Patents and Regulatory Information for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430-001 Aug 9, 2007 RX Yes Yes   Start Trial   Start Trial   Start Trial
B Braun CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430-002 Aug 9, 2007 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Express Scripts
Dow
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.